Labcorp Holdings Net Income 2010-2025 | LH
Labcorp Holdings annual/quarterly net income history and growth rate from 2010 to 2025. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
- Labcorp Holdings net income for the quarter ending March 31, 2025 was $0.213B, a 6.67% decline year-over-year.
- Labcorp Holdings net income for the twelve months ending March 31, 2025 was $0.731B, a 68.74% increase year-over-year.
- Labcorp Holdings annual net income for 2024 was $0.746B, a 78.47% increase from 2023.
- Labcorp Holdings annual net income for 2023 was $0.418B, a 67.32% decline from 2022.
- Labcorp Holdings annual net income for 2022 was $1.279B, a 46.2% decline from 2021.
| Labcorp Holdings Annual Net Income (Millions of US $) |
|
|---|---|
| 2024 | $746 |
| 2023 | $418 |
| 2022 | $1,279 |
| 2021 | $2,377 |
| 2020 | $1,556 |
| 2019 | $824 |
| 2018 | $884 |
| 2017 | $1,227 |
| 2016 | $712 |
| 2015 | $438 |
| 2014 | $511 |
| 2013 | $574 |
| 2012 | $583 |
| 2011 | $520 |
| 2010 | $558 |
| 2009 | $543 |
| Labcorp Holdings Quarterly Net Income (Millions of US $) |
|
|---|---|
| 2025-03-31 | $213 |
| 2024-12-31 | $143 |
| 2024-09-30 | $169 |
| 2024-06-30 | $205 |
| 2024-03-31 | $228 |
| 2023-12-31 | $-167 |
| 2023-09-30 | $183 |
| 2023-06-30 | $189 |
| 2023-03-31 | $213 |
| 2022-12-31 | $76 |
| 2022-09-30 | $353 |
| 2022-06-30 | $359 |
| 2022-03-31 | $492 |
| 2021-12-31 | $553 |
| 2021-09-30 | $587 |
| 2021-06-30 | $467 |
| 2021-03-31 | $770 |
| 2020-12-31 | $938 |
| 2020-09-30 | $703 |
| 2020-06-30 | $232 |
| 2020-03-31 | $-317 |
| 2019-12-31 | $227 |
| 2019-09-30 | $221 |
| 2019-06-30 | $190 |
| 2019-03-31 | $186 |
| 2018-12-31 | $158 |
| 2018-09-30 | $319 |
| 2018-06-30 | $234 |
| 2018-03-31 | $173 |
| 2017-12-31 | $688 |
| 2017-09-30 | $172 |
| 2017-06-30 | $185 |
| 2017-03-31 | $183 |
| 2016-12-31 | $164 |
| 2016-09-30 | $180 |
| 2016-06-30 | $204 |
| 2016-03-31 | $164 |
| 2015-12-31 | $110 |
| 2015-09-30 | $155 |
| 2015-06-30 | $170 |
| 2015-03-31 | $3 |
| 2014-12-31 | $120 |
| 2014-09-30 | $137 |
| 2014-06-30 | $141 |
| 2014-03-31 | $113 |
| 2013-12-31 | $126 |
| 2013-09-30 | $148 |
| 2013-06-30 | $152 |
| 2013-03-31 | $147 |
| 2012-12-31 | $120 |
| 2012-09-30 | $148 |
| 2012-06-30 | $153 |
| 2012-03-31 | $162 |
| 2011-12-31 | $135 |
| 2011-09-30 | $134 |
| 2011-06-30 | $123 |
| 2011-03-31 | $127 |
| 2010-12-31 | $132 |
| 2010-09-30 | $140 |
| 2010-06-30 | $154 |
| 2010-03-31 | $133 |
| 2009-12-31 | $143 |
| 2009-09-30 | $131 |
| 2009-06-30 | $136 |
| 2009-03-31 | $133 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $20.694B | $13.009B |
| Labcorp Holdings Inc. provides laboratory services which helps doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. Labcorp Holdings Inc., formerly known as LABORATORY CP, is based in BURLINGTON, N.C. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $139.405B | 26.15 |
| CVS Health (CVS) | United States | $80.076B | 9.95 |
| Elevance Health (ELV) | United States | $68.334B | 9.16 |
| Cencora (COR) | United States | $57.058B | 19.85 |
| DiDi Global (DIDIY) | China | $27.204B | 28.90 |
| Natera (NTRA) | United States | $19.578B | 0.00 |
| BioMerieux (BMXMF) | France | $16.861B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.895B | 0.00 |
| CochLear (CHEOY) | Australia | $13.107B | 0.00 |
| Solventum (SOLV) | United States | $12.779B | 13.53 |
| ICON (ICLR) | Ireland | $11.862B | 11.03 |
| Revvity (RVTY) | United States | $11.266B | 19.39 |
| Viatris (VTRS) | United States | $10.880B | 3.74 |
| Medpace Holdings (MEDP) | United States | $9.173B | 24.36 |
| Avantor (AVTR) | United States | $9.056B | 13.16 |
| Sonic Healthcare (SKHHY) | Australia | $8.822B | 0.00 |
| HealthEquity (HQY) | United States | $8.658B | 37.92 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.959B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.696B | 15.08 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $5.017B | 29.54 |
| BrightSpring Health Services (BTSG) | United States | $3.534B | 32.42 |
| Sotera Health (SHC) | United States | $3.188B | 18.11 |
| Surgery Partners (SGRY) | United States | $2.899B | 37.70 |
| Alignment Healthcare (ALHC) | United States | $2.602B | 0.00 |
| Concentras Parent (CON) | United States | $2.533B | 14.64 |
| Organon (OGN) | United States | $2.506B | 2.66 |
| GeneDx Holdings (WGS) | United States | $2.295B | 88.37 |
| Progyny (PGNY) | United States | $1.972B | 43.42 |
| PACS (PACS) | United States | $1.876B | 0.00 |
| Premier (PINC) | United States | $1.735B | 13.17 |
| GoodRx Holdings (GDRX) | United States | $1.689B | 33.79 |
| Ardent Health (ARDT) | United States | $1.656B | 7.06 |
| Teladoc Health (TDOC) | United States | $1.410B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $1.277B | 438.00 |
| Establishment Labs Holdings (ESTA) | $1.228B | 0.00 | |
| Pediatrix Medical (MD) | United States | $1.103B | 8.39 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.970B | 0.00 |
| Agilon Health (AGL) | United States | $0.898B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.779B | 7.29 |
| CareDx (CDNA) | United States | $0.658B | 10.27 |
| Nutex Health (NUTX) | United States | $0.615B | 9.32 |
| Embecta (EMBC) | United States | $0.576B | 3.88 |
| InnovAge Holding (INNV) | United States | $0.571B | 0.00 |
| SBC Medicals (SBC) | United States | $0.569B | 0.00 |
| So-Young (SY) | China | $0.507B | 0.00 |
| LifeMD (LFMD) | United States | $0.504B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.476B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.474B | 10.68 |
| Omada Health (OMDA) | $0.456B | 0.00 | |
| COMPASS Pathways (CMPS) | United Kingdom | $0.363B | 0.00 |
| Enhabit (EHAB) | United States | $0.337B | 27.75 |
| Oncology Institute (TOI) | United States | $0.326B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.315B | 0.00 |
| Beauty Health (SKIN) | United States | $0.209B | 0.00 |
| DocGo (DCGO) | United States | $0.148B | 24.17 |
| Pheton Holdings (PTHL) | China | $0.143B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.113B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.078B | 0.00 |
| KindlyMD (NAKA) | United States | $0.069B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.059B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.052B | 0.00 |
| Biodesix (BDSX) | United States | $0.046B | 0.00 |
| ModivCare (MODV) | United States | $0.044B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.038B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.019B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.015B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.012B | 0.00 | |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.007B | 0.00 |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |